CGIT SWOT

From HL7Wiki
Jump to: navigation, search

SWOT Analysis: Reviewed January 11, 2016 Status: Updated SWOT and Goals

Strengths

  • People want guidance on implementation and conformance
  • We have qualified team members
  • We have experience with all the product lines
  • We have real-hands-on experience in both implementation and testing

Weaknesses

  • Limited resources to support domain work groups conformance initiatives
  • Lack of awareness in other groups
  • Low feedback on open work items

Opportunities

  • FHIR
  • Conformance WG = central group to collect information from real projects
  • Enhance guidance for v2.x
  • Creating guidance for v2.x
  • Vocabulary conformance guidance
  • ARB and Product Line Task Force looking for consistent approach to conformance and testing
  • Define and operationalize the role of a conformance facilitators (approach Project Services, through Project Scope Statements)

Threats

  • FHIR
    • Conformance in FHIR is moving forward without Conformance WG participation
    • Implementors are not required to read base specification for FHIR and so are not aware of conformance constructs when using FHIR
  • Duplication of efforts and inconsistent strategy in domain projects in regards conformance
  • Lack of awareness of other groups (working on conformance specifications without notice)
    • Other committees do "their work" without any notification
    • Other committees do work, that should be done by Conformance WG

Goals

  • Create conformance alignment across all product lines (including terminology)
  • Provide consistent common guidance and in-depth guidance for projects
  • Create an FAQ for implementers (website)
  • Get more people involved in the Conformance WG
  • Engage with other work groups that are creating conformance guidance
  • Clarify with TSC about our mission and responsibilities
  • Assign conformance facilitator role to qualified individuals

Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.